Published in Medical Letter on the CDC and FDA, May 15th, 2005
On April 13, 2005, the United States District Court for the District of Utah, Central Division, granted Nutraceutical's motion for summary judgment against U.S. Food and Drug Administration (FDA) in Nutraceutical's lawsuit involving FDA's Final Rule on Ephedra.
Bruce Hough, president of Nutraceutical, commented the decision "is, in our view, about protecting the public's access to safe and effective dietary supplements and in clarifying the meaning of the 1994 Dietary Supplement Health and Education Act (DSHEA). The...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.